ad

Nifty Pharma Prediction for Tomorrow: Key Levels and Sector Outlook for 30 June 2026

Nifty pharma prediction for tomorrow: Nifty Pharma at 25,227.90 (+1.03%). Support 25,000. Resistance 25,450. Nifty 50 at 23,946 (-0.46%). VIX 13.56. Nifty expiry Tuesday 30 June.


29 Jun 20265:18 pm

Nifty Pharma Prediction for Tomorrow: Key Levels and Sector Outlook for 30 June 2026

Nifty pharma prediction for tomorrow, 30 June 2026, is bullish after the sector rose 1.03%, the best sectoral performance on Monday. Dr Reddy’s surged 1.87%, Cipla gained 0.97%, and Sun Pharma rose 0.64%, confirming the nifty pharma prediction for tomorrow as one of the strongest sector setups. Traders seeking accurate nifty pharma prediction for tomorrow data for Tuesday will find the complete analyst breakdown in this article. Understanding nifty pharma prediction for tomorrow on 30 June requires tracking both domestic institutional flows and overnight global signals before the 9:15 AM opening bell. Nifty pharma prediction for tomorrow levels, sector context, and analyst views are all covered below.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director, present the nifty pharma prediction for tomorrow for 30 June 2026. Both analysts note that Nifty 50 weekly expiry on Tuesday adds an extra volatility layer that traders must factor into their nifty pharma prediction for tomorrow position sizing.

Click Here – Get Free Investment Predictions

Today’s Market Recap for Nifty pharma prediction for tomorrow

  • Nifty Pharma (29 Jun): Closed at 25,227.90, up 1.03% from 24,969.50. High 25,463.70, low 24,978.05. Monday’s top-performing sector by a wide margin.
  • Strong Gainers: Dr Reddy’s surged 1.87%, Cipla rose 0.97%, and Sun Pharma gained 0.64%. All major pharma stocks posted gains, confirming broad institutional buying.
  • Defensive Rotation: Institutional investors rotated into Pharma from weak sectors (Auto -2.08%, IT -1.07%), confirming healthcare and pharma as the preferred defensive allocation in Monday’s risk-off environment.

Nifty Pharma: Nifty pharma prediction for tomorrow

Trend: Bullish | Support: 25,000 / 24,800 | Resistance: 25,450 / 25,700

Ankit Jaiswal notes the nifty pharma prediction for tomorrow is the most bullish of all NSE sector outlooks as all three major pharma stocks posted meaningful gains on Monday. Dr Reddy’s 1.87% surge suggests company-specific catalysts such as US FDA approvals or positive pipeline developments. Kunal Singla observes the nifty pharma prediction for tomorrow centres on the 25,450 resistance: a decisive break above this on Tuesday would signal continuation toward 25,700 and attract fresh momentum buyers.

Global Cues for 30 June 2026

  • US Markets: Dow 51,876 (-0.09%), Nasdaq 25,298 (-0.24%). A US futures recovery overnight is a key positive opening cue for Tuesday.
  • Crude Oil: MCX Crude closed at Rs 6,641 (+0.97%). Crude direction affects energy sector stocks and broader commodity sentiment on 30 June.
  • GIFT Nifty and Currency: Check GIFT Nifty at 8:30 AM IST for the gap-open signal. A firm Dollar Index adds FII flow headwinds for Indian equities on 30 June.

Key Events for Nifty pharma prediction for tomorrow

These triggers will most directly shape nifty pharma prediction for tomorrow on 30 June 2026:

  • Nifty 50 Expiry (Tuesday): Weekly contracts settle at 3:30 PM. Expiry volatility amplifies directional moves across indices and commodities.
  • Chicago PMI (June): Releases 30 June. A weak reading could weigh on global manufacturing sentiment and the Indian market opening direction.
  • US Quarter-End: 30 June ends Q2 2026 in the US. Institutional rebalancing creates rupee and GIFT Nifty pressure before the 9:15 AM opening.
  • Q1 FY27 Pre-positioning: Results season opens early July. Sector rotation already underway adds directional undertones to Tuesday’s session.

Sectors to Watch on 30 June

  • Pharma (+1.03%): Monday’s best performer. Defensive buying may continue Tuesday and support risk-off positioning.
  • Metal (+0.80%): Hindalco +1.11%, Tata Steel +0.46%. MCX base metal strength supports the sector into Tuesday’s session.
  • Auto (-2.08%): Monday’s sharpest fall. Watch for a technical bounce at support or continued weakness adding to the bearish broader backdrop.

Stocks to Watch for Nifty pharma prediction for tomorrow

Based on Monday’s close and nifty pharma momentum, Ankit Jaiswal and Kunal Singla flag these three stocks as the best nifty pharma prediction for tomorrow proxies for Tuesday. Reference levels only.

Stock CMP (29 Jun) Entry Zone Target 1 Target 2 Stop Loss
Sun Pharma Rs 1,874.80 Rs 1,868 to 1,878 Rs 1,892 Rs 1,910 Rs 1,848
Dr Reddys Laboratories Rs 1,375.70 Rs 1,368 to 1,382 Rs 1,398 Rs 1,418 Rs 1,350
Cipla Rs 1,454.10 Rs 1,448 to 1,460 Rs 1,476 Rs 1,498 Rs 1,432

Sun Pharma, Dr Reddys Laboratories, and Cipla are the most direct equity plays aligned with nifty pharma prediction for tomorrow on 30 June 2026. Ankit Jaiswal flags Sun Pharma as the lead indicator for nifty pharma on Tuesday.

Use the Univest Screener to Track Live Nifty Pharma Levels

For live price updates throughout Tuesday’s session, the Univest iOS and Android apps deliver real-time alerts and expert research directly to your mobile, so you never miss a critical level break on 30 June 2026.

Download the Univest iOS App or Univest Android App to receive daily nifty pharma prediction for tomorrow alerts and analyst research on your phone.

Market Sentiment and Nifty pharma prediction for tomorrow

Nifty pharma prediction for tomorrow for 30 June 2026 is shaped by three signals. First, India VIX at 13.56, rising from 13.05, indicates options participants are pricing in Tuesday expiry uncertainty into nifty pharma price ranges. Second, FII buying of Rs 384 Cr and DII buying of Rs 5,748 Cr on Monday provide a cushion that limits extreme downside for nifty pharma on Tuesday. Third, the nifty pharma prediction for tomorrow benefits from the sector’s dual role as both a defensive haven and structural growth sector, making it attractive to risk-off buyers and long-term growth investors simultaneously. Ankit Jaiswal expects the nifty pharma to trade within the 25,000 to 25,450 band for most of Tuesday before expiry-related volatility picks up in the final 30 minutes. Kunal Singla notes the bullish bias is intact but any overnight global surprise can significantly shift the 9:15 AM opening direction for nifty pharma prediction for tomorrow on 30 June.

Risks to Nifty pharma prediction for tomorrow

These four factors can sharply alter nifty pharma prediction for tomorrow on 30 June 2026:

  • US quarter-end rebalancing creating a gap-down via GIFT Nifty at 9:15 AM.
  • India VIX spiking above 15, widening spreads and forcing option unwinding.
  • Auto and IT sector weakness extending, pulling Nifty 50 below 23,900.
  • Crude spike or rupee past Rs 84.50 tightening conditions for rate-sensitive sectors.

Conclusion

Nifty pharma prediction for tomorrow for 30 June 2026 is bullish, with Nifty Pharma expected to trade between the 25,000 support and 25,450 resistance on Tuesday. Dr Reddy’s 1.87% surge is the standout catalyst for the nifty pharma prediction for tomorrow, and sustained momentum into Tuesday could pull the index toward the 25,700 upper resistance level. Ankit Jaiswal and Kunal Singla advise tight stop losses, checking GIFT Nifty before 9:15 AM, and keeping positions small given Nifty 50 weekly expiry on 30 June.

The overall outlook for 30 June 2026 favours a bullish stance unless a decisive directional break confirms either the 25,000 support holding or the 25,450 resistance giving way in early trade. Track live levels on the Univest Screener and app for real-time updates throughout Tuesday’s session.

Disclaimer: Data in this article are sourced from publicly available information and may not be accurate. Verify with NSE (nseindia.com) and BSE (bseindia.com) before investing. Investments are subject to market risk. Educational content only, not investment advice by Univest (SEBI RA INH000013776).

FAQs on

1. What is the for 30 June 2026?

Ans. The for 30 June 2026 is bullish. Support is at 25,000 and 24,800. Resistance stands at 25,450 and 25,700. Ankit Jaiswal and Kunal Singla advise tight stop losses given Nifty 50 weekly expiry volatility on Tuesday.

2. What are the key levels in for Tuesday?

Ans. In for 30 June, support is at 25,000 and 24,800. Resistance is at 25,450 and 25,700. A break below 25,000 confirms bullish momentum in while a move above 25,450 signals a short-term reversal for Nifty Pharma on Tuesday.

3. What factors drive ?

Ans. The key factors shaping on 30 June are US FDA drug approval calendar for Indian companies, domestic healthcare spending growth, global generic drug demand, API input cost direction, and export earnings for the . Traders should also monitor India VIX at 13.56 and Nifty 50 weekly expiry at 3:30 PM on Tuesday, as expiry swings amplify directional moves relevant to nifty pharma prediction for tomorrow.

4. How do global cues affect nifty pharma prediction for tomorrow?

Ans. Global cues affect nifty pharma prediction for tomorrow through US FDA approval outcomes for Indian drug companies, global generic drug pricing trends, and currency movements affecting rupee earnings from US drug exports in the nifty pharma prediction for tomorrow. US market performance on Monday (Dow -0.09%, Nasdaq -0.24%) sets the overnight risk tone, while GIFT Nifty at 8:30 AM gives the most precise opening direction for Nifty Pharma on 30 June 2026.

5. Which stocks reflect nifty pharma prediction for tomorrow movement?

Ans. Sun Pharma is the largest Indian pharmaceutical company. Dr Reddy’s is the most US-FDA-sensitive stock with heavy ANDA filings. Cipla has a balanced domestic-export revenue mix. The three stocks above, Sun Pharma, Dr Reddys Laboratories, and Cipla, are the primary equity proxies for tracking nifty pharma prediction for tomorrow on 30 June 2026, each linked to the Univest stock page for live price tracking during Tuesday’s session.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Univest

100% Safe and Secure Platform

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down